BE waiver for proportional formula [Regulatives / Guidelines]

posted by m.ross – Switzerland, 2018-03-15 13:11 (2290 d 06:09 ago) – Posting: # 18553
Views: 2,171

The proportional waiver is for your product and not for the reference. Assuming that there is nothing strange in the labelling of the reference indicating that their two doses are not equivalent (like a statement that 2 x 20mg is not equivalent to 1 x 40mg) then there should be no issue.

Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5. Please follow the Forum’s Policy[Helmut]

Complete thread:

UA Flag
 Admin contact
23,059 posts in 4,841 threads, 1,664 registered users;
44 visitors (0 registered, 44 guests [including 4 identified bots]).
Forum time: 20:20 CEST (Europe/Vienna)

[…] an inappropriate study design is incapable of answering
a research question, no matter how careful the subsequent
methodology, conduct, analysis, and interpretation:
Flawless execution of a flawed design achieves nothing worthwhile.    J. Rick Turner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz